Biofrontera Inc reports results for the quarter ended September 30 - Earnings Summary

• Biofrontera Inc BFRI.OQ reported a quarterly adjusted loss of 98 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-4.64. The mean expectation of two analysts for the quarter was for a loss of 83 cents per share. Wall Street expected results to range from -94 cents to -73 cents per share.

• Revenue rose 1.3% to $9.01 million from a year ago; analysts expected $10.01 million.

• Biofrontera Inc's reported EPS for the quarter was a loss of 98 cents​.

• The company reported a quarterly loss of $5.67 million.

• Biofrontera Inc shares had fallen by 29.2% this quarter and lost 66.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 72.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Biofrontera Inc is 11.50

This summary was machine generated from LSEG data November 14 at 03:52 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)